Annual Current Assets
$459.12 M
-$69.71 M-13.18%
31 December 2023
Summary:
Allogene Therapeutics annual total current assets is currently $459.12 million, with the most recent change of -$69.71 million (-13.18%) on 31 December 2023. During the last 3 years, it has fallen by -$386.01 million (-45.68%). ALLO annual current assets is now -45.68% below its all-time high of $845.13 million, reached on 31 December 2020.ALLO Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$304.42 M
-$152.71 M-33.41%
30 September 2024
Summary:
Allogene Therapeutics quarterly total current assets is currently $304.42 million, with the most recent change of -$152.71 million (-33.41%) on 30 September 2024. Over the past year, it has dropped by -$169.04 million (-35.70%). ALLO quarterly current assets is now -66.53% below its all-time high of $909.58 million, reached on 30 June 2020.ALLO Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -13.2% | -35.7% |
3 y3 years | -45.7% | -39.5% |
5 y5 years | -1.9% | -40.3% |
ALLO Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -45.7% | at low | -46.5% | at low |
5 y | 5 years | -45.7% | at low | -66.5% | at low |
alltime | all time | -45.7% | -66.5% | +23.1% |
Allogene Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $304.42 M(-33.4%) |
June 2024 | - | $457.12 M(+15.6%) |
Mar 2024 | - | $395.36 M(-13.9%) |
Dec 2023 | $183.72 M(-37.2%) | $459.12 M(-3.0%) |
Sept 2023 | - | $473.45 M(-5.7%) |
June 2023 | - | $502.10 M(+4.3%) |
Mar 2023 | - | $481.46 M(-9.0%) |
Dec 2022 | $292.75 M(-49.5%) | $528.82 M(-7.1%) |
Sept 2022 | - | $569.06 M(+10.9%) |
June 2022 | - | $513.03 M(+9.2%) |
Mar 2022 | - | $469.74 M(-0.3%) |
Dec 2021 | $579.50 M | $471.32 M(-6.3%) |
Sept 2021 | - | $502.86 M(-16.5%) |
Date | Annual | Quarterly |
---|---|---|
June 2021 | - | $602.17 M(-15.9%) |
Mar 2021 | - | $716.06 M(-15.3%) |
Dec 2020 | $382.70 M(+120.9%) | $845.13 M(-1.0%) |
Sept 2020 | - | $854.06 M(-6.1%) |
June 2020 | - | $909.58 M(+80.3%) |
Mar 2020 | - | $504.41 M(-7.4%) |
Dec 2019 | $173.23 M(-43.4%) | $544.58 M(+6.8%) |
Sept 2019 | - | $509.76 M(-0.3%) |
June 2019 | - | $511.54 M(+7.3%) |
Mar 2019 | - | $476.63 M(+1.8%) |
Dec 2018 | $305.87 M(>+9900.0%) | $467.98 M(+89.2%) |
Sept 2018 | - | $247.35 M(-15.9%) |
June 2018 | - | $294.26 M |
Dec 2017 | $0.00 | - |
FAQ
- What is Allogene Therapeutics annual total current assets?
- What is the all time high annual current assets for Allogene Therapeutics?
- What is Allogene Therapeutics annual current assets year-on-year change?
- What is Allogene Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly current assets year-on-year change?
What is Allogene Therapeutics annual total current assets?
The current annual current assets of ALLO is $459.12 M
What is the all time high annual current assets for Allogene Therapeutics?
Allogene Therapeutics all-time high annual total current assets is $845.13 M
What is Allogene Therapeutics annual current assets year-on-year change?
Over the past year, ALLO annual total current assets has changed by -$69.71 M (-13.18%)
What is Allogene Therapeutics quarterly total current assets?
The current quarterly current assets of ALLO is $304.42 M
What is the all time high quarterly current assets for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly total current assets is $909.58 M
What is Allogene Therapeutics quarterly current assets year-on-year change?
Over the past year, ALLO quarterly total current assets has changed by -$169.04 M (-35.70%)